• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC
Click for more information
4.53% $1.73

RACE ONCOLOGY LTD

Market Cap $294.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
Pillar 1 - FTO (new thread)
49 50 51
19:44 3.0K 1.0M
19:44 Last post  Mason14 Comments Created with Sketch.  3.0K  Views Created with Sketch.  1.0M 
RAC
RAC - Charts & Price Action
371 372 373
16:52 22K 7.8M
16:52 Last post  Davisite Comments Created with Sketch.  22K  Views Created with Sketch.  7.8M 
RAC
Ann: HealthInvest 2024 Investor Presentation 		16:08 22 6.1K
16:08 Last post  IndexInvestor Comments Created with Sketch.  22  Views Created with Sketch.  6.1K 
RAC
General Comments / Chat
190 191 192
15:02 11K 4.0M
15:02 Last post  couldwellb Comments Created with Sketch.  11K  Views Created with Sketch.  4.0M 
RAC
Chat GPT Q&A
2 3 4
14:38 209 78K
14:38 Last post  Boffin99 Comments Created with Sketch.  209  Views Created with Sketch.  78K 
RAC
RAC media coverage
37 38 39
20/09/24 2.2K 774K
20/09/24 Last post  Teeth Comments Created with Sketch.  2.2K  Views Created with Sketch.  774K 
RAC
CPACS: Research, Results, Market Comparisons, and Valuations
3 4 5
19/09/24 271 80K
19/09/24 Last post  Davisite Comments Created with Sketch.  271  Views Created with Sketch.  80K 
RAC
CEO of Race Oncology posting on a public internet forum
2
19/09/24 74 21K
19/09/24 Last post  guessingame Comments Created with Sketch.  74  Views Created with Sketch.  21K 
RAC
Industry news
38 39 40
19/09/24 2.3K 784K
19/09/24 Last post  ttppxx Comments Created with Sketch.  2.3K  Views Created with Sketch.  784K 
RAC
Ann: Application for quotation of securities - RAC 		13/09/24 0 531
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  531 
RAC
Q. Why doesn't RAC raise more capital and run more trials? 		11/09/24 11 4.5K
11/09/24 Last post  Davisite Comments Created with Sketch.  11  Views Created with Sketch.  4.5K 
RAC
Race Oncology $3 Milestone Cycling Gear
3 4 5
10/09/24 246 76K
10/09/24 Last post  IndexInvestor Comments Created with Sketch.  246  Views Created with Sketch.  76K 
RAC
Speculative M&A Transaction Analysis
13 14 15
07/09/24 854 312K
07/09/24 Last post  arsenal1954 Comments Created with Sketch.  854  Views Created with Sketch.  312K 
RAC
Ann: Application for quotation of securities - RAC 		06/09/24 10 3.0K
06/09/24 Last post  IAmShovel Comments Created with Sketch.  10  Views Created with Sketch.  3.0K 
RAC
Ann: Notification of cessation of securities - RAC 		05/09/24 2 1.1K
05/09/24 Last post  RaceOncology Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
RAC
Ann: Race Oncology Board Renewal Update
2
04/09/24 108 31K
04/09/24 Last post  longtak Comments Created with Sketch.  108  Views Created with Sketch.  31K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

HealthInvest 2024 Investor Presentation
18 Sep 09:50
 
Application for quotation of securities - RAC
13 Sep 13:12
 
Application for quotation of securities - RAC
05 Sep 12:48
 
Notification of cessation of securities - RAC
05 Sep 09:33
 
Appendix 3X - Dr Serge Scrofani
02 Sep 09:15
 
Appendix 3X - Dr Daniel Tillett
02 Sep 09:14
 
View More arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.

(20min delay)
Last
$1.73 		Change
0.075(4.53%) 		Mkt cap ! $294.8M
Open High Low Value Volume
$1.66 $1.73 $1.64 $271.9K 161.8K

Buyers (Bids)

No. Vol. Price($)
1 300 $1.73
 

Sellers (Offers)

Price($) Vol. No.
$1.73 3844 2
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
$1.70 		  Change
0.075 ( 2.72 %)
Open High Low Volume
$1.66 $1.72 $1.65 9051
Last updated 15.51pm 20/09/2024 ?
RAC (ASX) Chart

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.